Dr. Loydie Jerome-Majewska’s Project Secures Major Funding

17 Mar 2025 Unclassified
Congratulations to Loydie A. Jerome-Majewska (Research Institute of the McGill University Health Centre) and the Canadian Black Scientist Network (CBSN) for securing a majour funding! The project, “Genomic Evidence for Precision Medicine for Selected Chronic Diseases Among Black Peoples in Canada,” will receive up to $17.7 million over four years, with Genome Canada contributing up to $8.3 million.

At its core, this initiative focuses on leveraging genomic data to enhance precision medicine approaches for chronic diseases, including those with genetic underpinnings

The project is led by a distinguished team of researchers, including:

Dr. Loydie Jerome-Majewska (McGill University/McGill University Health Centre) – Co-founder of CBSN, renowned for her expertise in developmental genetics and congenital disorders.

Dr. Juliet Daniel (McMaster University) – Co-founder of CBSN, with expertise in cancer genetics and molecular biology.

Dr. Upton Allen (Hospital for Sick Children) – CBSN Member & Keynote Speaker at BE-STEMM 2024, specializing in pediatric infectious diseases and immunogenetics.

Dr. OmiSoore Dryden (Dalhousie University) – CBSN Member & Panelist at BE-STEMM 2024, advocating for equitable healthcare policies.

For the reproductive research community, this initiative marks a significant step in understanding genetic risks, improving early diagnostics, and developing targeted interventions for hereditary diseases. The insights gained could lead to more personalized approaches to prenatal screening, genetic counseling, and early treatment strategies.

We celebrate this milestone and look forward to the advancements this research will bring to reproductive and precision medicine!

Search

+